Role of Inflammasomes in Keloids and Hypertrophic Scars—Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis

• Published in: International Journal of Molecular Sciences Vol. 23; no. 12; p. 6820
• Main Authors: Huang, Chenyu, Ogawa, Rei
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 19.06.2022; MDPI
• Subjects: Angiogenesis; Chemokines; Cicatrix, Hypertrophic; Cytokines; Dendritic cells; Diabetes; Diabetes Mellitus; Endothelial Cells; Fibroblasts; Fibrosis; Growth factors; Humans; Inflammasomes; Inflammation; Keloid; Mechanotransduction, Cellular; Microorganisms; Pathogens; Proteins; Review; Scars; Skin; Skin Diseases; Tumor necrosis factor-TNF; Wound healing
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23126820

Keloids and hypertrophic scars are pathological cutaneous scars. They arise from excessive wound healing, which induces chronic dermal inflammation and results in overwhelming fibroblast production of extracellular matrix. Their etiology is unclear. Inflammasomes are multiprotein complexes that are important in proinflammatory innate-immune system responses. We asked whether inflammasomes participate in pathological scarring by examining the literature on scarring, diabetic wounds (also characterized by chronic inflammation), and systemic sclerosis (also marked by fibrosis). Pathological scars are predominantly populated by anti-inflammatory M2 macrophages and recent literature hints that this could be driven by non-canonical inflammasome signaling. Diabetic-wound healing associates with inflammasome activation in immune (macrophages) and non-immune (keratinocytes) cells. Fibrotic conditions associate with inflammasome activation and inflammasome-induced transition of epithelial cells/endothelial cells/macrophages into myofibroblasts that deposit excessive extracellular matrix. Studies suggest that mechanical stimuli activate inflammasomes via the cytoskeleton and that mechanotransduction-inflammasome crosstalk is involved in fibrosis. Further research should examine (i) the roles that various inflammasome types in macrophages, (myo)fibroblasts, and other cell types play in keloid development and (ii) how mechanical stimuli interact with inflammasomes and thereby drive scar growth. Such research is likely to significantly advance our understanding of pathological scarring and aid the development of new therapeutic strategies.